Chemed Co. (NYSE:CHE) Shares Sold by Barclays PLC

Barclays PLC reduced its stake in Chemed Co. (NYSE:CHE - Free Report) by 16.1% in the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 9,795 shares of the company's stock after selling 1,877 shares during the quarter. Barclays PLC owned about 0.07% of Chemed worth $5,887,000 as of its most recent SEC filing.

A number of other institutional investors also recently bought and sold shares of CHE. American National Bank & Trust purchased a new stake in Chemed during the 3rd quarter valued at about $61,000. GAMMA Investing LLC boosted its position in Chemed by 60.5% in the third quarter. GAMMA Investing LLC now owns 138 shares of the company's stock valued at $83,000 after buying an additional 52 shares during the last quarter. Quarry LP increased its holdings in Chemed by 721.7% in the 2nd quarter. Quarry LP now owns 189 shares of the company's stock worth $103,000 after buying an additional 166 shares during the period. Sound Income Strategies LLC purchased a new position in Chemed during the 3rd quarter worth approximately $201,000. Finally, Farther Finance Advisors LLC lifted its stake in Chemed by 2,314.3% during the 3rd quarter. Farther Finance Advisors LLC now owns 338 shares of the company's stock valued at $203,000 after acquiring an additional 324 shares during the period. 95.85% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling

In related news, Director George J. Walsh III sold 400 shares of the firm's stock in a transaction dated Thursday, September 26th. The shares were sold at an average price of $597.47, for a total value of $238,988.00. Following the transaction, the director now directly owns 3,046 shares of the company's stock, valued at approximately $1,819,893.62. This trade represents a 11.61 % decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, EVP Spencer S. Lee sold 732 shares of Chemed stock in a transaction that occurred on Wednesday, November 27th. The stock was sold at an average price of $575.62, for a total value of $421,353.84. Following the completion of the sale, the executive vice president now directly owns 18,287 shares in the company, valued at $10,526,362.94. This represents a 3.85 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders sold 5,132 shares of company stock valued at $3,003,502. 3.32% of the stock is owned by company insiders.

Wall Street Analyst Weigh In

A number of analysts have recently weighed in on the stock. Royal Bank of Canada cut their price objective on shares of Chemed from $697.00 to $633.00 and set an "outperform" rating on the stock in a research note on Tuesday, November 5th. StockNews.com raised Chemed from a "hold" rating to a "buy" rating in a research report on Saturday, November 30th.

Chemed Trading Up 0.3 %

Chemed stock traded up $1.37 during mid-day trading on Friday, hitting $523.16. The company had a trading volume of 241,923 shares, compared to its average volume of 87,427. The company has a market capitalization of $7.87 billion, a price-to-earnings ratio of 26.44, a P/E/G ratio of 2.32 and a beta of 0.46. Chemed Co. has a 12-month low of $516.91 and a 12-month high of $654.62. The company's fifty day moving average is $564.38 and its 200-day moving average is $563.89.

Chemed (NYSE:CHE - Get Free Report) last announced its quarterly earnings results on Tuesday, October 29th. The company reported $5.64 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $5.76 by ($0.12). Chemed had a return on equity of 27.86% and a net margin of 12.69%. The firm had revenue of $606.18 million for the quarter, compared to analysts' expectations of $612.22 million. During the same period last year, the company posted $5.32 earnings per share. The business's quarterly revenue was up 7.4% on a year-over-year basis. As a group, sell-side analysts expect that Chemed Co. will post 21.43 EPS for the current fiscal year.

Chemed Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Friday, December 6th. Investors of record on Monday, November 18th were paid a $0.50 dividend. The ex-dividend date was Monday, November 18th. This represents a $2.00 annualized dividend and a dividend yield of 0.38%. Chemed's dividend payout ratio is presently 10.11%.

Chemed Company Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.